STOCK TITAN

Taro to Release Second Quarter Results on October 26, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Taro Pharmaceutical to release Q2 2023 financial results
Positive
  • None.
Negative
  • None.

HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the second quarter ended September 30, 2023, after the close of market on Thursday, October 26, 2023.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

William J. Coote

VP, Chief Financial Officer

(914) 345-9001

William.Coote@taro.com

Source: Taro Pharmaceutical Industries Ltd.

FAQ

When will Taro Pharmaceutical release its Q2 2023 financial results?

Taro Pharmaceutical plans to release its Q2 2023 financial results on Thursday, October 26, 2023.

Where can I access the financial results?

The financial results will be accessible on Taro's website at www.taro.com.

Taro Pharmaceutical Industries Ltd.

NYSE:TARO

TARO Rankings

TARO Latest News

TARO Stock Data

1.62B
8.09M
78.48%
13.06%
0.2%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Haifa